Physician profile
Sandra L Shepherd
NPI 1720171994
$631.49
in general payments reported to CMS, 2019-2025
16 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.66 · 2022: $71.96 · 2023: $303 · 2024: $95.25 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $113.57 | 2023-2025 | Qulipta, Ubrelvy |
| Inspire Medical Systems, INC. | $85.71 | 2023 | Inspire |
| Glaxosmithkline, LLC. | $71.65 | 2021-2025 | Shingrix, Bexsero, Penmenvy |
| Amgen INC. | $70.24 | 2022-2025 | Evenity, Prolia |
| Novo Nordisk INC | $57.29 | 2022-2024 | Rybelsus, Wegovy |
| Pfizer INC. | $37.35 | 2023 | |
| Xeris Pharmaceuticals, INC. | $24.75 | 2025 | Keveyis |
| Myriad Women'S Health, INC. | $23.37 | 2023 | Myrisk |
| Exeltis, USA INC. | $21.99 | 2023 | Slynd |
| Sanofi Pasteur INC. | $21.22 | 2025 | |
| Astellas Pharma US INC | $20.98 | 2023 | Veozah |
| Lilly USA, LLC | $18.60 | 2024 | Mounjaro |
| Exact Sciences Corporation | $17.64 | 2023 | Cologuard Collection Kit |
| Coopersurgical, INC. | $16.92 | 2024 | Paragard T 380a |
| Astrazeneca Pharmaceuticals LP | $15.21 | 2024 | Airsupra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linus Health, INC. | $15.00 | 2024 | Core Cognitive Evaluation |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Shepherd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.